El En SpA
MIL:ELN
El En SpA
MIL:ELN
Price:
11.52 EUR
0.61%
Market Closed
Updated:
May 12, 2024
Section:
Relative Value
The Relative Value of one
ELN
stock under the Base Case scenario is
16.29
EUR.
Compared to the current market price of 11.52 EUR,
El En SpA
is
Undervalued by 29%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ELN
Relative Value
Base Case
16.29
EUR
Undervaluation 29%
Valuation Multiples
Multiples Across Competitors
ELN Competitors Multiples
El En SpA Competitors
El En SpA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IT |
|
El En SpA
MIL:ELN
|
920.8m EUR | 1.3 | 19.1 | 9.6 | 11.2 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
182.2B USD | 4.5 | 32.4 | 19.1 | 28.5 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
137.2B USD | 18.7 | 69 | 56.6 | 71 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.9B USD | 6 | 37.5 | 24.3 | 29.9 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
110.1B USD | 3.4 | 26.2 | 13.9 | 19.7 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
108.3B USD | 7.4 | 61.3 | 30.8 | 45.6 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
68.1B USD | 3.5 | 55.9 | 18.7 | 39.5 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
58.7B EUR | 2.7 | 38.6 | 18.5 | 31.3 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
52.2B USD | 8.5 | 36.9 | 26.8 | 29 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.5B CNY | 10.3 | 30.3 | 27.8 | 27.8 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
50.3B USD | 13.2 | 78.7 | 58.8 | 76.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
